SGMT – sagimet biosciences inc. (US:NASDAQ)
Stock Stats
News
Sagimet Biosciences (SGMT) is now covered by Rodman & Renshaw. They set a "buy" rating and a $28.00 price target on the stock.
Sagimet Biosciences (SGMT) was upgraded by Wall Street Zen from "sell
Sagimet Biosciences (SGMT) had its "buy" rating reaffirmed by HC Wainwright. They now have a $29.00 price target on the stock.
Sagimet Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Updates [Yahoo! Finance]
Sagimet Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Updates
Form S-8 Sagimet Biosciences Inc.
Form S-8 Sagimet Biosciences Inc.
Form 8-K Sagimet Biosciences Inc. For: Mar 11
Form 10-K Sagimet Biosciences Inc. For: Dec 31
Form 4 Sagimet Biosciences Inc. For: Feb 19 Filed by: Rozek Elizabeth
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.